Treatment-related Hypertension as a Prognostic Factor for De Novo Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Real-world Evidence Study

Treatment-related Hypertension as a Prognostic Factor for De Novo Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Real-world Evidence Study

Background and objective: Hypertension (HTN) has been linked to an elevated risk of prostate cancer (PC) development and poorer prognosis in localized cases, and is a common side effect of hormonal PC treatments. However, its relationship with the prognosis of metastatic PC is still unclear. We asse...

Full description

Saved in:
Bibliographic Details
Main Authors: Giuseppe Salfi, Martino Pedrani, Selin Candan, Vasile Urechie, Sara Merler, Lorenzo Ruinelli, Amos Colombo, Luis Castelo-Branco, Irene Testi, Fabio Turco, Luigi Tortola, Ursula Vogl, Luca Gabutti, Silke Gillessen, Ricardo Pereira Mestre
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:European Urology Open Science
Subjects:
Hypertension
Prostate cancer
Side effects
Androgen deprivation treatment
Androgen receptor inhibitors
Androgen receptor pathway inhibitor
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168324014149
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items